Kisqali 200 MG daily dose UU 21S
Ended Awarded
- Contract number
- SPE2DB25FCXTZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,405
Award facts
- Contract value 100% obligated
- $14,404.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,404.73 to AmerisourceBergen Drug Corp for the supply of Kisqali 200 mg daily dose in unit of use packaging containing 21 tablets. The contract, awarded on June 16, 2025, with an ultimate completion date of June 17, 2025, utilizes firm fixed price pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's IDC with DLA enables it to supply a broad range of pharmaceutical products and medical supplies to support Defense Health Agency operations and other government healthcare systems globally. The current delivery order for Kisqali, a cancer treatment medication, exemplifies the company's role in fulfilling specialized pharmaceutical requirements across multiple therapeutic domains through the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FCXTZ?
SPE2DB25FCXTZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 16, 2025.
How much is contract SPE2DB25FCXTZ worth?
The government has obligated $14,405 on SPE2DB25FCXTZ.
Is contract SPE2DB25FCXTZ an order under another contract?
Yes. SPE2DB25FCXTZ is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FCXTZ competed?
The extent of competition for SPE2DB25FCXTZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award